Australians have expressed concern over extremely high costs for psychedelic-assisted therapies after the medicines were given the green light for use to treat depression and other severe mental health issues earlier this year.
Australia saw a landmark change in stature last month when the Australian Therapeutic Goods Association (TGA) made the decision to authorise the use of psychedelic drugs across authorised pharmacies.
The decision would allow drugs such as MDMA and…
